Peer Review reports
From: SNHG1 opposes quiescence and promotes docetaxel sensitivity in prostate cancer
| Original Submission | ||
|---|---|---|
| 1 Dec 2022 | Submitted | Original manuscript |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| 13 Jan 2023 | Reviewed | Reviewer Report - Liudmila Spirina |
| 17 Jan 2023 | Reviewed | Reviewer Report - Dirk Geerts |
| 31 Jan 2023 | Reviewed | Reviewer Report |
| 8 May 2023 | Author responded | Author comments - Frank C. Cackowski |
| Resubmission - Version 3 | ||
| 8 May 2023 | Submitted | Manuscript version 3 |
| 9 May 2023 | Author responded | Author comments - Frank C. Cackowski |
| Resubmission - Version 4 | ||
| 9 May 2023 | Submitted | Manuscript version 4 |
| 10 May 2023 | Author responded | Author comments - Frank C. Cackowski |
| Resubmission - Version 5 | ||
| 10 May 2023 | Submitted | Manuscript version 5 |
| 20 May 2023 | Reviewed | Reviewer Report - Liudmila Spirina |
| 21 May 2023 | Reviewed | Reviewer Report - Dirk Geerts |
| Resubmission - Version 6 | ||
| Submitted | Manuscript version 6 | |
| Publishing | ||
| 25 May 2023 | Editorially accepted | |
| 18 Jul 2023 | Article published | 10.1186/s12885-023-11006-x |
You can find further information about peer review here.